This Is MS Multiple Sclerosis Community: Knowledge & Support

Merck Serono, a division of Germany's Merck, announced that the U.S. Food and Drug Administration (FDA) approved Rebif(R) Rebidose(R) (interferon beta-1a), a single-use auto-injector for the self-administration of Rebif, a disease-modifying drug used to treat relapsing forms of multiple sclerosis (MS).

Rebif Rebidose was evaluated in a 12-week Phase IIIb multicenter, open-label, single-arm study for the self-administration of Rebif with respect to ease of use, patient satisfaction and acceptability, and functional reliability. In the trial, patients with relapsing MS, who were receiving Rebif 44 microgram three times weekly for more than 12 weeks, continued MS therapy using Rebif Rebidose for 12 weeks. The results of the trial showed that the majority of patients found the device easy to use. ... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/3560

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis

I have never had to inject myself with anything before. Now that I am recently diagnosed with RRMS, my neurologist wants me to research Rebif and start me on it next month. Sure hope the Rebidose will make it easy on me, I HATE NEEDLES.